BCL2 and cancer: For example, the distribution of CLIFI values for BCL2 indicates that it is importance in the classification of several cancers, each of which appear to have bi- or multimodal distributions (hinting at heterogeneity), and specifically with thyroid and kidney renal papillary cell (higher expression) and oesophageal, mesothelioma, liver, pancreatic and adrenocortical (lower expression) cancers.